The formation of the coronary vessel system is vital for heart development, an essential step of which is the establishment of a capillary plexus that displays a density gradient across the myocardial wall, being higher on the epicardial than the endocardial side. This gradient in capillary plexus formation develops concurrently with transmural gradients of myocardium-derived growth factors, including FGFs. To test the role of the FGF expression gradient in patterning the nascent capillary plexus, an ectopic FGF-over-expressing site was created in the ventricular myocardial wall in the quail embryo via retroviral infection from E2-2.5, thus abolishing the transmural gradient of FGFs. In FGF virus-infected regions of the ventricular myocardium, the capillary density across the transmural axis shifted away from that in control hearts at E7. This FGF-induced change in vessel patterning was more profound at E12, with the middle zone becoming the most vascularized. An up-regulation of FGFR-1 and VEGFR-2 in epicardial and subepicardial cells adjacent to FGF virus-infected myocardium was also detected, indicating a paracrine effect on induction of vascular signaling components in coronary precursors. These results suggest that correct transmural patterning of coronary vessels requires the correct transmural expression of FGF and, therefore, FGF may act as a template for coronary vessel patterning. D
Introduction
An adequate blood supply for the working myocardium is essential for heart function. Before the coronary circulatory system is formed, the myocardial wall is avascular and believed to be nourished by diffusion through the endocardium, via trabecular channels that markedly increase endocardial surface area (Rychter and Ostádal, 1971; Rychterova, 1971) . The endothelial, vascular smooth muscle and other mural cells of the coronary vasculature are derived from the epicardium (Dettman et al., 1998; Li et al., 2002; Mikawa and Fischman, 1992; Mikawa and Gourdie, 1996; Pérez-Pomares et al., 1998) . These precursors begin to contact the heart tube among the proepicardium at around HH17. Epicardial cells destined to contribute to intramural coronary vessels undergo an epithelial-mesenchyme transformation, delaminate and invade the myocardium to form a capillary plexus that is formed by a vasculogenic process (Mikawa and Fischman, 1992 ). This capillary network is then remodeled into the mature, intramural coronary blood vessels (for a review, see Bernanke and Velkey (2002) ), eventually forming a closed coronary vascular system at HH32 in the quail (Vrancken Peeters et al., 1997) .
As the myocardium develops, the nascent coronary capillary plexus displays a density gradient across the transmural axis of the myocardial wall, being higher on the outer, epicardial side than the inner, endocardial side (Tomanek et al., 1999b) . The formation of the capillary plexus in the myocardium is an essential stage in the formation of the coronary vasculature. However, it is unknown what patterns the capillary plexus gradient across the transmural axis of the myocardium.
There is evidence from a number of species that, concomitant with the formation of the coronary capillary plexus, there are also gradients of growth factors implicated in blood vessel formation that also show higher expression in the outer, epicardial, than the inner, endocardial, side of the myocardium. These include FGF1 and FGF2 in the chick embryo (Consigli and Joseph-Silverstein, 1991; Pennisi et al., 2003) and FGF2 in the bovine heart (Kardami and Fandrich, 1989) . Moreover, VEGF, one of the most potent vasculogenic and angiogenic growth factors (for review, see Neufeld et al. (1999) ) is expressed with a similar transmural gradient in the rodent embryo heart (Tomanek et al., 1999b) . These observations have lead to a hypothesis that a gradient of hypoxia is important in patterning the capillary plexus along the transmural axis of the myocardium (Tomanek et al., 1999a,b) . Importantly, the expression of all of these factors has not been described in detail in relation to coronary vessel patterning in a single species.
FGFs and VEGF have been shown to act directly on endothelial cells, affecting different processes involved in vessel induction and formation, including differentiation, proliferation and cell migration (for reviews, see (Neufeld et al., 1999; Presta et al., 2000) ). In addition, there is evidence that FGFs can act upstream of the VEGF signaling pathway, up-regulating expression of VEGF (Seghezzi et al., 1998; Tille et al., 2001 ) and VEGFR-2 (Pepper and Mandriota, 1998) , further supporting a possible role for FGFs in the formation or patterning of vascular networks.
It is, therefore, clear that there is communication between the FGF and VEGF signaling pathways, at least in vessel development, although the underlying mechanisms are not well understood. Moreover, less is known about the interaction between these two signaling cascades in heart development and how this may relate to coronary vessel development. Our previous work has demonstrated that ectopic over-expression of FGFs in coronary vascular cell precursors promotes the formation and branching of coronary blood vessels in an autocrine manner (Hyer et al., 1999) . Thus, we hypothesized that the gradient of FGF across the transmural axis of the myocardium acts as a template for the formation of the coronary capillary plexus.
We tested this hypothesis by examining the relationship between the transmural gradient of growth factor expression and the patterning of the nascent, intramural coronary vessels in the quail embryo. We describe that between E7 and E14 in wild-type quail embryos there is a gradient of myocardial expression of FGF1, FGF2 and VEGF that is higher adjacent to the epicardium than endocardium. Concordant with this, the density of the intramural vasculature is higher in the outer, epicardial region of the myocardium. We then over-expressed FGF ligand to alter the transmural gradient of FGF across the myocardium wall. The resultant embryos displayed a shift in the gradient of vessel density across the myocardial wall with the change in FGF expression. Furthermore, FGFR-1 and VEGFR-2 were up-regulated in epicardial and subepicardial cells adjacent to myocytes overexpressing FGF, alluding to a mechanism by which myocyte-derived FGFs may act to produce a vesselpromoting effect in a paracrine manner. Therefore, we conclude that patterning of the intramural coronary vessels requires the correct expression gradient of FGFs across the transmural axis of the myocardium.
Methods and materials

Embryonic manipulations
Fertile quail eggs were purchased from CBT Farms (Chestertown, Maryland) and incubated at 388C under humidified conditions. Embryos were staged according to the number of days of incubation or by the staging system of Hamburger and Hamilton (Hamburger and Hamilton, 1951) .
Immunohistochemistry
Immunohistochemistry was performed using standard techniques as previously described (Pennisi et al., 2003) . The following primary antibodies were used for immunostaining histological sections: anti-FGF1 antibody (cat. # sc-1884, Santa Cruz Biotechnology Inc., CA, USA), anti-FGF2 antibody (cat. # sc-79, Santa Cruz Biotechnology Inc., CA, USA), anti-FGFR-1 (Flg) antibody (cat. # sc-15, Santa Cruz Biotechnology Inc., CA, USA), QH1 antibody (Developmental Studies Hybridoma Bank, The University of Iowa, Department of Biological Sciences, Iowa City, IA 52242), anti-VEGF antibody (cat. # sc-152, Santa Cruz Biotechnology Inc., CA, USA) and anti-VEGFR-2 (cat. # sc-505, Santa Cruz Biotechnology Inc., CA, USA).
Injection of retroviral constructs
High titer preparations (10 7 -10 8 plaque forming units/ ml) of replication-incompetent retroviruses were prepared and pressure-injected in ovo into the pericardial space of HH11-13 embryos to infect myocardial cells as previously described (Mikawa and Fischman, 1992) . The retroviruses employed in this study have been published previously: CXL (expressing h-galactosidase), SNFGF1lZ (expressing FGF1 fused with a secretion signal and hgalactosidase from a di-cistronic mRNA) and SNFGF4lZ (expressing FGF4 with an authentic secretion signal and h-galactosidase from a di-cistronic mRNA). The biological activity and paracrine effects of FGFs expressed from these viral vectors in avian embryos have been reported elsewhere (Hyer et al., 1999 (Hyer et al., , 1998 (Hyer et al., , 2003 Itoh et al., 1996; Mikawa et al., 1991; Mima et al., 1995a,b; Sugi et al., 2003) . Hearts were dissected for analysis at various stages of development (embryonic days (E) 7, E10 and E12) in phosphate buffered saline (PBS), fixed in 2% paraformaldehyde (PFA) in PBS at 48C for 2-4 h and stained with X-gal at 378C overnight. After numerous washes in PBS and whole-mount photography, selected samples were dehydrated in an ethanol series, cleared in CitriSolv (Fisher Scientific, USA) and embedded in paraffin. Serial, 7 Am, transverse sections were cut and mounted on Superfrost slides (VWR, USA).
Data documentation and analysis
Images were captured using either a Digital Photo Camera (DKC-5000, Sony) or a Spot RT Slider (2.3.1, Diagnostic Instruments Inc., USA) using Adobe Photoshop (version 7.0, Adobe Systems Inc.) or Spot (version 3.2.6 Diagnostic Instruments Inc, USA) software, respectively. Images were adjusted for color levels, brightness and contrast, and figures were then compiled, using Adobe Photoshop software (version 7.0, Adobe Systems Inc.).
Quantification of vessel density
Analyses were conducted on the left and right ventricular free wall, at approximately the midpoint of the ventricle along the apex-base axis. The compact myocardium was defined as the region between the epicardium and the lower limit of the trabeculae. For the purposes of transmural quantification, the myocardium was divided into three regions along the transmural axis, the inner, middle and outer myocardial wall (see Fig. 2 ). The radial borders for regions of analyses (for wild-type and virus-infected regions) were lines drawn at right angles to the outer curvature of the myocardium. All quantification was conducted using Adobe Photoshop (version 7.0, Adobe Systems Inc.). This included the determination of area in pixels (converting to Am 2 where appropriate). Quantification of vessel density after QH1 immunostaining on histological sections was performed on digitally recorded images of 20Â magnification. For the purposes of objectivity in determining the intensity and area of DAB immunostaining, digital images were adjusted in Adobe Photoshop thus; to avoid confounding background from X-Gal staining, the blue (R 20, G 80, B 120) was lightened by 85% (bReplace ColorQ function). Brightness and contrast were increased by 30% each. Images were then converted to a binary mode by converting pixels to either black or white (bThresholdQ function), where all pixels above the threshold (set at 200 here) in luminance were converted to white and all those below were converted to black. The areas of selected regions, either black or white were calculated using the histogram of the levels of the pixels (in the bThresholdQ dialogue box). The area of immunostaining (black pixels) was then converted to Am 2 . Three regions of both the right and left ventricles from different wild-type (WT) hearts were quantified at E7, E10 and E12. Standard deviation from the mean (SDM) was calculated for groups of quantitative data. Statistical significance was determined using a Student's two-tailed t test.
Results
Growth factor expression and capillary patterning across the myocardial wall
In the first set of experiments, developmental changes in the expression pattern of FGF, and VEGF, as well as coronary vessel formation across the transmural axis of the developing myocardium, were examined in the quail embryo. Our analysis focused on developmental stages between embryonic day 7 (E7) and E14, when the capillary plexus is forming and being remodeled, and until the time the coronary vascular system connects to the systemic circulatory system (Rychter and Ostádal, 1971; Rychterova, 1971; Vrancken Peeters et al., 1997) . FGF1, FGF2, VEGF and endothelial cells of the coronary vasculature were immunolocalized in the ventricular myocardium.
At E7, the formation of nascent coronary capillary plexus was detectable in the compact myocardium (Figs. 1A, B). By E10, more and larger vessels formed in the outermost region (adjacent to the epicardium) than the inner region (adjacent to the endocardium) of the compact myocardium (Figs. 1F, G). This gradient across the transmural axis of the compact myocardium became more prominent at E12 (Figs. 1K, L) and persisted at E14 (Figs. 1P, Q). At E7, FGF1, FGF2 and VEGF, proteins were detected throughout the myocardium and epicardium (Figs. 1C-E). Stronger signals, particularly for FGF2 and VEGF, were detected in the outermost region of the compact myocardium compared to the inner, subendocardial region. Similarly, at E10 and E12, this pattern of growth factor expression was maintained in the compact myocardium (Figs. 1H-J, M-O). At E14, the transmural gradient of FGF1, FGF2 and VEGF expression persisted and the portion of the myocardium with higher protein levels became a more restricted, narrow region subjacent to the epicardium (Figs. 1R-T). At all stages examined, we observed FGF1 and/or FGF2 in the cytoplasm as well as associated with the extracellular space. We also found strong perinucleolar immunostaining for FGF1 at E7 (Figs. 1C, CV) and cytoplasmic staining in a subpopulation of the trabecular myocardium at E10 (Fig. 1H ). Despite the dynamic expression pattern, the strong immunostaining of FGF1 was consistently detected at the outer myocardium between E7-E14. These data show that a gradient of FGF1, FGF2 and VEGF expression across the transmural axis of the myocardium is established during capillary patterning in the embryonic quail heart, consistent with studies on FGF1 and FGF2 in the chick heart (Consigli and JosephSilverstein, 1991; Pennisi et al., 2003) , FGF2 in the bovine heart (Kardami and Fandrich, 1989) and VEGF in the rodent heart (Tomanek et al., 1999b) .
Vessel density gradient across the transmural axis of the myocardium
To quantify the above visual inspection of a transmural gradient in coronary plexus formation, vessel density was measured individually at an inner, middle and outer zone of the compact myocardium, using morphometric analyses (Fig. 2) . Vessel density in each of these sub-regions was estimated using two parameters, the number of vessels/Am 2 and vessel area per region (expressed as a percentage). At E7, a stage shortly after angioblasts invade the myocardium, both the right and left ventricles were clearly trabeculate (Figs. 2B, C). Also evident at this stage was the thin nature of the compact myocardium relative to later stages. The mean values for the number of vessels/Am 2 at the inner, middle and outer regions of the right ventricle were 1.2 Â 10 À5 , 3.3 Â 10 À5 and 2.0 Â 10 À5 (SDM 4.5 Â 10 À6 , 1.1 Â 10 À5 and 9.0 Â 10 À6 ), respectively (Fig. 2H ). For the left ventricle, the values were 1.7 Â 10 À5 (inner), 2.2 Â 10
À5
(middle) and 1.9 Â 10 À5 (outer) (SDM 4.7 Â 10 À6 , 7.0 Â 10 À6 and 7.9 Â 10 À6 , respectively). The mean values for vessel area at the inner, middle and outer regions for the right ventricle were 14.5% (F4.7%), 30.5% (F13.2%) and 39.3% (F22%), respectively (Fig. 2I) . Similarly, in the left ventricle, the vessel density for the inner, middle and outer regions were 26.9% (F9.2%), 33.9% (F7.6%) and 42.3% (F14.8%), respectively. Taken together, the data show that capillary plexus formation is most active in the outermost region of the myocardium at this developmental stage.
At E10 (Figs. 2D, E) , an intermediate stage in coronary plexus formation, the trabeculae were still conspicuous but somewhat diminished compared to E7. The compact myocardium at this stage was thicker than at E7. The mean values of the number of vessels/Am 2 at the inner, middle and outer regions of the right ventricle were 2.9 Â 10 À5 , 3.5 Â 10 À5 and 4.5 Â 10 À5 (SDM 1.1 Â 10 À5 , 1.0 Â 10 À5 and 1.7 Â 10 À5 ), respectively (Fig. 2H) . For the left ventricle, the values were Fig. 1 . There is a transmural gradient across the myocardial wall of vessel density and vessel-promoting growth factors in the developing avian heart. (A-E) E7; (F-J) E10; (K-O) E12; (P-T) E14 (scale bars, 50 Am). Panels CV-SV are higher magnification views of the outer myocardium (arrows) in panels C-S (scale bar, 5 Am). Immunohistochemical detection of vascular endothelia with the QH1 antibody (B, G, L and Q) reveals the nascent capillary network in the compact myocardium with a greater number of vessels in the outermost region. This difference becomes more prominent at E12 and E14. Concomitant with the development of the coronary capillary plexus is expression of known vessel-promoting factors, FGF1 (C, H, M and R), FGF2 (D, I, N and S) and VEGF (E, J, O and T), where a higher level of expression is in the outermost region of the myocardium, subjacent to the epicardium (indicated by arrows). This transmural pattern is evident from E7 to E14. No signal was detected in non-immune serum controls (A, F, K and P). Open arrowheads, nuclear and/or perinucleolar localization of FGF1; asterisks, zones exhibiting higher immunostaining of cytoplasmic and/or extracellular FGF1 and FGF2.
2.5 Â 10 À5 (inner), 2.8 Â 10 À5 (middle) and 3.8 Â 10
(outer) (SDM 8.0 Â 10 À6 , 7.2 Â 10 À6 and 9.8 Â 10 À6 , respectively). The mean values of vessel areas at the inner, middle and outer regions for the right ventricle were 20.3% (F15.2%), 23.5% (F12.5%) and 42% (F26%), respectively. Similarly, in the left ventricle, the vessel areas at the inner, middle and outer regions were measured as 19.3% (F9.6%), 19.5% (F6.7%) and 35.3% (F10.8%), respectively (Fig. 2I) . Fig. 2 . Quantification of the transmural gradient of vessel density in wild-type quail hearts at E7, E10 and E12. (A) Diagrammatic representation of the regions of the myocardial compact layer analyzed for vessel density quantification for the left ventricle (LV) and right ventricle (RV) and the subdivision of the myocardial free wall into an bouterQ (o), bmiddleQ (m) and binnerQ (i) zone for quantification of vessel density in this study (see Methods and materials). Examples of QH1 immunostaining are shown for the right and left ventricle at E7 (B and C, respectively), at E10 (D and E, respectively) and E12 (F and G, respectively) . Summaries of the mean values for wild-type vessel densities in terms of number of vessels/Am 2 (H) and vessel area as a percentage (I) are given for the inner, middle and outer regions of the compact myocardium at E7, E10 and E12. The sub-regions of the compact myocardium are denoted by varying shades of gray; lightest for binnerQ, medium for bmiddleQ and darkest for bouterQ. Asterisks denote a statistically significant difference ( P b 0.05) in vessel density for a particular sub-region relative to the outermost (o) region of that particular ventricle at that developmental stage. Note that the transmural gradient of vessel density becomes more pronounced as development proceeds, both in terms of number of vessels/Am 2 and percentage vessel area. ep, epicardium; cm, compact myocardium; tr, trabeculae; en, endocardium. The mean values for the wild-type controls are indicated. Error bars, standard deviation of the mean. Scale bar, 100 Am.
As in E7 hearts, the percentage vessels area in E10 hearts was highest in the outer region both for the left and right ventricles.
At E12, the trabeculae became much less conspicuous and the coronary vessel network was more patterned, including vessels exhibiting a larger lumen than at E7 and E10, particularly in the left ventricle. Furthermore, the outermost and innermost capillaries were oriented perpendicular to the plane of section. The mean values of the number of vessels/Am 2 at the inner, middle and outer regions of the right ventricle were 2.0 Â 10 À5 , 2.2 Â 10 À5 and 4.5 Â 10 À5 (SDM 4.3 Â 10 À6 , 3.5 Â 10 À6 and 9.8 Â 10 À6 ), respectively (Fig. 2H) . For the left ventricle, the values were 2.5 Â 10 À5 (inner), 2.2 Â 10 À5 (middle) and 3.8 Â 10
(outer) (SDM 4.1 Â 10 À6 , 4.9 Â 10 À6 and 9.5 Â 10 À6 , respectively). The values for the inner, middle and outer regions for the right ventricle at E12 were 12.2% (F4.2%), 9.7% (F5%) and 28% (F11.6%), respectively (Fig. 2I) . Similarly, in the left ventricle, the vessel density for the inner, middle and outer regions were 7.7% (F3%), 9.3% (F2.4%) and 26.6% (F6.4%), respectively. Thus, the transmural gradient of vessel densities (the relative proportion of the inner, middle and outer regions) was more pronounced at E12 than at E7 and E10 in both the right and left ventricles.
Production and analysis of FGF virus-infected hearts
To test whether the gradient of FGF across the transmural axis of the myocardium acts as a template for the formation of the coronary capillary plexus, the endogenous FGF gradient was abolished by expressing exogenous FGF locally in the ventricular myocardium through infection with replicationdeficient retroviral vectors. The vectors used expressed either FGF1 (SNFGF1lZ) or FGF4 (SNFGF4lZ) and h-galactosidase (h-gal) from di-cistronic mRNA or h-gal alone (CXL) (Fig. 3A) . The FGF4-expressing retroviral vector was included as control of as other studies have demonstrated a response by endothelial cells to FGF4 expression in a paracrine manner (Dell'Era et al., 2001 ). Viral particles were injected into the pericardial cavity of stage HH11-13 (E2-2.5) quail embryos in ovo before proepicardium formation was evident, thus avoiding epicardial infection (Fig. 3B ). Hearts were harvested at E7, E10 and E12 and survival was assessed by the presence or absence of a beating heart. The survivability of embryos that received FGF1 virus injection compared with CXL-injected hearts was 16/35 (46%) and 13/19 (68%) at E7, respectively; 11/32 (34%) and 11/20 (55%) at E10, respectively and 11/50 (22%) and 11/23 (48%) at E12, respectively. The survival rates of FGF4 virusinjected were lower than those infected with FGF1 virus, with 19/37 (51%) at E7, 4/29 (14%) at E10 and 0/23 (0%) at E12. Regions containing virus-infected myocytes were identified by whole-mount X-Gal staining of hearts (Figs. 3C-J) followed by histological sectioning. Sections displaying XGal-positive areas were then processed for QH1 immunohistochemistry and vessel density analysis. For vessel density analyses, FGF1 and FGF4 virus-injected samples were grouped together for comparison to control samples. Fig. 3 . Experimental protocol used for retroviral over-expression of FGFs in the myocardium of embryonic quail hearts. A, diagrammatic representation of the replication-incompetent retroviral vectors used in the study; CXL (expressing LacZ), SNFGF1lZ (expressing FGF1 fused to a secretion signal (asterisk) and LacZ from a di-cistronic mRNA) and SNFGF4lZ (expressing FGF4 encoding an authentic secretion signal (asterisk) and LacZ from a di-cistronic mRNA). B, example of retroviral injection into the pericardial cavity of a stage HH11 embryo. Examples of whole-mount, X-Gal-stained hearts. Ventral and dorsal views of representative examples of hearts dissected and X-Gal-stained at E7 (C-E), E10 (F-H) and E12 (I, J) are shown. Note that at E7 and E10, lower levels of infection were observed in FGF4 virus-injected hearts relative to FGF1 virus-injected hearts.
Changes in the transmural gradient of vessel density in FGF virus-infected hearts
Vessel densities were examined in regions of the myocardium where infection with FGF viruses was evident across the myocardial wall or more prominently in the inner and middle zones relative to the outer zone. At E7, FGF virus-infected hearts exhibited an overall increase in the number of vessels in all the regions of the compact myocardium compared to those infected with control CXL virus (Figs. 4A-C, F, G) . Both control and the majority of FGF virus-infected regions showed a similar transmural pattern in the number of vessels/Am 2 between the inner, middle and outer regions (i.e., the transmural gradient) of the compact myocardium at this stage. Both test and control hearts developed a higher number of vessels/Am 2 at the middle region than the outer and inner regions (Fig. 4F) . While no significant change was detected in the gradient of vessel density across the myocardium in terms of number of vessels/Am 2 , more than half the FGF virus-infected hearts exhibited a shift in vessel density gradient in vessel area away from the outermost region being the highest, having higher values for the inner or middle sub-region rather than the outer (Fig. 4G) .
At E12, FGF virus-infected hearts displayed more pronounced changes both in the relative proportions of the number and area of vessels across the compact myocardium (Figs. 4D, E, H, I ). Four of seven samples exhibited a strong shift and one a mild shift in vessel numbers, with the highest value in the middle region (Fig. 4H) . In addition, up to a three-fold increase in the average vessel size in the inner, middle and outer zones of the myocardium was detected at all FGF virus-infected regions. Importantly, the majority also showed a significant increase in vessel area in the inner and middle regions relative to that in the outer region (Fig. 4I) . Thus, the data suggest that a local expression of exogenous FGF gives rise to a shift in the gradient of vessel density away from the outermost region to the middle region of the compact myocardium at E12.
The above morphometric analyses revealed that in regions of the right ventricular myocardium infected with FGF1-and FGF4 virus, there was an overall increase in the number and volume of vessels in all compact myocardial regions (summarized in Fig. 5 ). Importantly, a change in the capillary density across the transmural axis was also evident with a shift in vessel distribution away from gradient observed in control hearts. These effects were more pronounced at E12 than at E7.
Subepicardial up-regulation of FGFR-1 and VEGFR-2 in response to myocardial over-expression of FGFs
FGF is a regulator of the expression of VEGF signaling components, including VEGF receptor expression in endothelial cells (Pepper and Mandriota, 1998) . A positive feedback effect of FGFs on FGF receptor expression is also reported (Estival et al., 1996; Saito et al., 1991) . Although a gradient of FGFR-1 expression across the transmural axis of the myocardium has been reported by us and others (Patstone et al., 1993; Pennisi et al., 2003) , we have focused our attention on the possible paracrine effect on myocardium-derived FGFs on the epicardial-derived coronary precursors. Thus, we hypothesized that a change in VEGFR and FGFR expression in coronary precursor and vasculature may be associated with a shift of vessel patterning induced by an altered FGF gradient across the myocardium. Therefore, to test this possibility, the expression of VEGFR-2 and FGFR-1 in coronary vasculature was examined in FGF virus-infected and control hearts using immunohistochemistry. While no significant change in FGFR-1 and VEGFR-2 immunosignals in the myocardium between control CXL virus-and FGF virus-infected hearts was observed, more FGFR-1-positive cells were detected among epicardial cells and those in the subepicardial space adjacent to FGF virus-infected myocardium compared to controls at Fig. 5 . Summary of the changes in the gradient of vessel density across the myocardial transmural axis in FGF virus-infected hearts. Asterisks denote a statistically significant difference ( P b 0.05) in vessel density in FGF expressing virus-infected sub-regions (Fig. 4) relative to the corresponding wild-type control (Fig. 2) . The sub-regions of the compact myocardium are denoted by varying shades of gray; lightest for binnerQ, medium for bmiddleQ and darkest for bouterQ. RV, right ventricle; i, inner; m, middle; o, outer. The mean values for the wild-type controls are included for ease of comparison. Error bars, standard deviation of the mean. E7 (Figs. 6A-D) . The up-regulation of FGFR-1 expression appeared more pronounced in epicardial and subepicardial cells at E10 adjacent to FGF virus-infected than CXL virusinfected myocardium (Figs. 6E-H) . By contrast, there was no detectable difference in the intensity or number of VEGFR-2-immunoreactive epicardial or subepicardial cells in regions adjacent to FGF virus-infected myocardium at E7 (Figs. 6I-L) . At E10, however, there were an increased number of VEGFR-2-immunoreactive subepicardial cells in regions adjacent to FGF virus-infected myocardium (Figs. 6M-P). These data show that epicardial and subepicardial cells can respond to myocardium-derived FGF, indicating a possible mechanism by which paracrine signals may induce vessel formation among coronary precursors.
Discussion
The formation of a functional coronary vasculature is essential for proper heart development. An essential component of this is establishing an intramural capillary plexus that is remodeled into a functional coronary vasculature. It remains to be determined, however, what mechanism(s) patterns this capillary plexus (Galoforo et al., 1996; Kim et al., 2002; Seghezzi et al., 1998; Tille et al., 2001; Tomanek et al., 1999a,b; Zheng et al., 2001) . In this study, we have shown that a myocardial FGF gradient plays a crucial role in the regulation of the vessel density gradient that is higher in the outermost region of the compact myocardium. Representative examples are shown for control virus-infected samples at E7 (A and I) and E10 (E and M) and FGF virus-infected samples at E7 (C and K) and E10 (G and O). Higher magnification views of the boxed areas in panels A, C, E, G, I, K, M and O are shown in panels B, D, F, H, J, L, N and P, respectively. FGFR-1 and VEGFR-2 are up-regulated in subepicardial cells (indicated by arrows) in proximity to FGF virusinfected myocardium relative to control virus-infected samples. Note that immunohistochemistry was performed in a way that ensured identical staining times between test and control samples and before high levels of expression were detected in surrounding regions (such as the myocardium) or the immunostaining became over-stained. Scale bar, 50 Am.
Our morpohometric analysis of vessel formation in the compact myocardium has revealed a progressive patterning process of the coronary capillary plexus across the transmural axis of the ventricular myocardium during the second week of quail embryo development. Our data are consistent with a transmural gradient of vessel formation found in rat embryonic hearts (Tomanek et al., 1996) , suggesting a common patterning process in embryonic hearts both of birds and mammals. Together with previous studies in chick and rat embryos (Consigli and Joseph-Silverstein, 1991; Kardami and Fandrich, 1989; Pennisi et al., 2003; Tomanek et al., 1999b) , our immunohistochemical data show that the gradient of the expression of vessel-promoting growth factors, FGFs and VEGF, occurs concomitantly with the development of the transmural gradient of vessel density across species.
FGFs have long been implicated in vessel development and can influence the proliferation, migration and differentiation of vascular cells (for review, see Detillieux et al. (2003) ). In the bird, ectopic FGF2 can induce QH1 expression among somitic mesoderm indicating angioblast induction, as well as inducing vessel formation in the quail embryo (Cox and Poole, 2000) . The role of FGFs in vascular development is further complicated by the fact that FGF2 has been shown to up-regulate VEGF and VEGFR-2 (Pepper and Mandriota, 1998; Seghezzi et al., 1998; Tille et al., 2001) . Therefore, FGFs can promote vessel growth by acting directly on endothelial cells (Cummins, 1993; Risau and Flamme, 1995) and indirectly through VEGF signaling. VEGF, however, has not been shown to up-regulate FGFs or their high affinity receptors. Although there is evidence for a communication between the FGF and VEGF pathways, they may also act independently and, therefore, be controlled in different ways.
Experimental evidence on the heart has shown that FGF2 is involved in arteriolar formation and VEGF and FGF2 together appear to modulate coronary capillary angiogenesis . FGF1 has been suggested to act on coronary endothelial cells in a paracrine manner (Engelmann et al., 1993) . In addition, our previous work has demonstrated that over-expression of FGFs in coronary vascular cell precursors promotes the formation and branching of coronary blood vessels in an autocrine manner (Hyer et al., 1999) . These data, with the transmural gradient of FGFs expression coincident with coronary vessel formation (Consigli and Joseph-Silverstein, 1991; Kardami and Fandrich, 1989; Pennisi et al., 2003) , suggested a role of FGFs in coronary patterning (Tomanek et al., 1996) . Direct experimental evidence on modulating the transmural gradient of FGF expression, however, has been lacking. Transgenic mice over-expressing FGF1 in the myocardium displayed an increase in the density of coronary arteries, particularly arterioles, although early stages of coronary vessel formation were not examined (Fernandez et al., 2000) . In these mice, the endogenous transmural gradient of FGF1 was further enhanced, not abolished, by transgenesis.
To overcome the technical difficulties sometimes encountered in some transgenic and knock-out mice, replication-incompetent retroviral vectors were used in this study to over-express FGF ligands locally in the myocardium in the quail embryo, thus abolishing the endogenous transmural gradient of FGF. This allowed us to experimentally address the relationship between the observed gradient of myocardium-derived FGF and the gradient of the developing, intramural vasculature in mosaic transgenic embryos, thus avoiding potential lethality with wholeembryo transgenesis. Our data show that altering the gradient of FGF expression levels across the transmural axis of the myocardial wall results in a concomitant shift in the gradient of vessel density. Thus, the data we present here provide evidence that the pattern of FGF expression in the myocardium may act as a template for the patterning of the coronary capillary plexus. This study has also shown that altering the transmural gradient of FGF expression across the myocardium not only shifts the gradient of capillary density, but also increases vascularization in all zones of the myocardium at the stages examined. This is consistent with the known effect of FGFs on promoting vascular development (Cummins, 1993; Risau and Flamme, 1995) .
What remains unclear is what controls FGF expression in the developing myocardium and how this relates, specifically, to coronary vessel patterning. Numerous stimuli could potentially contribute to induction of FGF expression in the developing myocardium and thus contribute to the patterning of the coronary vasculature. These include intrinsic, genetic and epigenetic factors, paracrine signals from other tissues or biomechanical and physical stimuli. Our previous studies have shown that the transmural gradient of FGF (and FGFR-1) expression in the developing myocardium is maintained in the absence of the epicardium, albeit at reduced levels (Pennisi et al., 2003) . This indicated that paracrine signaling alone between adjacent tissues could not account for the gradient of growth factor expression across the transmural axis of the myocardium. Biophysical stimuli could include hypoxia (Tomanek et al., 1999a,b; Yue and Tomanek, 1999) , hypoglycemia (Galoforo et al., 1996) and stretch or pressure load (Kim et al., 2002; Zheng et al., 2001 ), all of which can up-regulate the expression of factors that promote vascular formation. Although shear stress has been shown to up-regulate FGFs in several cell types (Malek et al., 1993; Singh et al., 1998) , it seems unlikely that cardiomyocytes would be directly subject to shear stress resulting from laminar flow.
Hypoxia has also been hypothesized to be a factor in patterning the intramural capillary network (Tomanek et al., 1999a,b; Yue and Tomanek, 1999) . The developing ventricular myocardium is hypoxic (Lee et al., 2001) and it is believed that the immature, avascular myocardium is nourished by diffusion from the lumen of the heart chambers and, therefore, the outermost regions of the compact myocardium would be most hypoxic. Furthermore, components of the hypoxia-responsive pathway (HIF-1a and ARNT) are indispensable for vascular development (Adelman et al., 2000; Maltepe et al., 1997) . It is well established that hypoxia induces VEGF expression (Neufeld et al., 1999) and that a transmural gradient of VEGF expression has been reported in the embryonic rat heart (Tomanek et al., 1999b) . The responsiveness of FGF expression to hypoxia, however, is less well established. FGF1 and FGF2 have been shown to be up-regulated under hypoxic conditions in cultured carcinoma cells (Lee and Corry, 1999) , glial cells (Ganat et al., 2002) and mononuclear phagocytes (Kuwabara et al., 1995) , and, moreover, that FGF2 can enhance vascularization responsiveness under hypoxic conditions (Li et al., 2003) . Conversely, some studies failed to find an up-regulation of FGFs under hypoxic conditions in retinal cells (Shima et al., 1995) and in an avascular, in vivo tumor model (Fang et al., 2001) .
FGFs are involved in other processes in the developing heart: FGFs are important for cardiac myocyte proliferation, particularly at earlier stages (Mima et al., 1995b) and FGF2 has been implicated in cardiac hypertrophy in the adult myocardium (reviewed by Detillieux et al. (2003) ). Cardiac myocytes are capable of producing FGF2 in response to mechanical load (Kaye et al., 1996b) and FGF is upregulated in the adult heart by ischemia or hemodynamic burden (Schneider et al., 1992) . Furthermore, FGFs in the cytoplasmic of myocytes can be released after stress or injury (Clarke et al., 1993 (Clarke et al., , 1995 Kardami et al., 1991; Kaye et al., 1996a) . It is, therefore, difficult to separate myocardial growth and response to physical stimuli and factors that may affect coronary vascularization. Experimentally pressureoverload hearts resulting in hypertrophy does not result in an increase in capillary density (Murray et al., 1979; Tomanek et al., 1999a) , indicating a strict control of vessel density and, presumably, the molecular cues that govern their formation. Direct experimental evidence that biophysical factors, for example, act via FGF in the developing myocardium to pattern the nascent coronary capillary network is lacking. Furthermore, interpretation would be confounded by the fact that biomechanical forces acting on and by the myocardium itself can promote expression of growth factors by myocytes (Schneider et al., 1992; Zheng et al., 2001) or release following physical damage (Clarke et al., 1993 (Clarke et al., , 1995 Kardami et al., 1991; Kaye et al., 1996a) .
FGFs act in a paracrine manner, signaling through their high-affinity receptors (Okada-Ban et al., 2000) . In addition, FGFs have been shown to up-regulate FGFR-1 mRNA in mouse mammary tumor cells (Saito et al., 1991 ) and a pancreatic cell line (Estival et al., 1996) and can also upregulate VEGFR-2 (Pepper and Mandriota, 1998) . In this study, we found that epicardial and subepicardial cells adjacent to myocardium over-expressing FGF up-regulated FGFR-1 and VEGFR-2, consistent with previous reports on the biological activity of FGF. As the expressions of both FGFR-1 and VEGFR-2 are up-regulated in a population of cells that contain coronary precursors, we are given some clue as to the mechanism of action of the paracrine signal involved in coronary induction and this may include signaling through more than one pathway. The precise relationship of the molecular pathways involved in this paracrine interaction involving myocardium-derived signals and epicardiumderived coronary precursors, however, remains to be elucidated. Retroviral targeting to modulate specific factors in coronary precursors may better define the role various receptors and signaling pathways could play in the paracrine induction and patterning of the capillary network.
We have begun to address the role the transmural gradient of myocardium-derived FGF ligands may play in acting as a template for the developing coronary vasculature. Future work on elucidating the mechanism(s) by which FGFs are regulated in the myocardium, and how this affects the early stages of coronary development, will prove to be an important step toward understanding how the coronary vasculature forms and may provide an avenue for therapeutic intervention in clinical situations.
